H.R. 1051

Title:  To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.
Sponser: Budzinski, Nikki [Rep.-D-IL-13] (Introduced 02/06/2025)
Latest Action:
Permanent Link:
pdf:
html:
txt:

02/06/2025

119th Congress (2025-2026)

https://www.congress.gov/bill/119th-congress/house-bill/1051

Category:

Leave the first comment